Shah, M., Montesinos, P., Cheong, J.-W., Daver, N., Fathi, A. T., Levis, M. J., … Erba, H. P. (2025). QuANTUM-Wild: Phase 3, Randomized, Double-Blind Quizartinib Study in Newly Diagnosed, FLT3-ITD-Negative Acute Myeloid Leukemia. In BRITISH JOURNAL OF HAEMATOLOGY (Vol. 206).

Shah, Mili, Pau Montesinos, June-Won Cheong, Naval Daver, Amir T. Fathi, Mark J. Levis, Selina Luger, et al. “QuANTUM-Wild: Phase 3, Randomized, Double-Blind Quizartinib Study in Newly Diagnosed, FLT3-ITD-Negative Acute Myeloid Leukemia.” In BRITISH JOURNAL OF HAEMATOLOGY, Vol. 206, 2025.

Shah M, Montesinos P, Cheong J-W, Daver N, Fathi AT, Levis MJ, et al. QuANTUM-Wild: Phase 3, Randomized, Double-Blind Quizartinib Study in Newly Diagnosed, FLT3-ITD-Negative Acute Myeloid Leukemia. In: BRITISH JOURNAL OF HAEMATOLOGY. 2025.

Shah, Mili, et al. “QuANTUM-Wild: Phase 3, Randomized, Double-Blind Quizartinib Study in Newly Diagnosed, FLT3-ITD-Negative Acute Myeloid Leukemia.” BRITISH JOURNAL OF HAEMATOLOGY, vol. 206, 2025.

Shah M, Montesinos P, Cheong J-W, Daver N, Fathi AT, Levis MJ, Luger S, Miyamoto T, Oliva EN, Perl AE, Recher C, Schlenk R, Wang J, Zeidan AM, Liu L, Duong Y, Imadalo K, Alexis K, Nahar A, Burns K, Erba HP. QuANTUM-Wild: Phase 3, Randomized, Double-Blind Quizartinib Study in Newly Diagnosed, FLT3-ITD-Negative Acute Myeloid Leukemia. BRITISH JOURNAL OF HAEMATOLOGY. 2025.